{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:41:51Z","timestamp":1791452511198,"version":"4.3.3"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.21346","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T15:31:46Z","timestamp":1657639906000},"page":"e2221346","source":"Crossref","is-referenced-by-count":55,"title":["Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use"],"prefix":"10.1001","volume":"5","author":[{"suffix":"Jr","given":"Carl G.","family":"Streed","sequence":"first","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts"},{"name":"Center for Transgender Medicine and Surgery, Boston Medical Center, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake R.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Health Law, Policy, and Management, Boston University School of Public Health, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mam Jarra","family":"Gai","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Larochelle","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts"},{"name":"Grayken Center for Addiction, Boston Medical Center, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Paasche-Orlow","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts"},{"name":"Grayken Center for Addiction, Boston Medical Center, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"zoi220609r1","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","article-title":"Responding to outbreaks of human immunodeficiency virus among persons who inject drugs\u2014United States, 2016-2019: perspectives on recent experience and lessons learned.","volume":"222","author":"Lyss","year":"2020","journal-title":"J Infect Dis"},{"issue":"9883","key":"zoi220609r2","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"22","key":"zoi220609r4","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1001\/jama.2019.6390","article-title":"Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement.","volume":"321","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi220609r5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","article-title":"Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.","volume":"14","author":"Walters","year":"2017","journal-title":"Harm Reduct J"},{"key":"zoi220609r6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.drugalcdep.2017.12.028","article-title":"Sex work, injection drug use, and abscesses: associations in women, but not men.","volume":"185","author":"Wurcel","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi220609r7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10461-016-1612-6","article-title":"Primary care physicians\u2019 willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs.","volume":"21","author":"Edelman","year":"2017","journal-title":"AIDS Behav"},{"issue":"12","key":"zoi220609r8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","article-title":"Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs.","volume":"32","author":"Bazzi","year":"2018","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"zoi220609r9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2105\/AJPH.2021.306208","article-title":"Delivering preexposure prophylaxis to people who use drugs and experience homelessness, Boston, MA, 2018-2020.","volume":"111","author":"Biello","year":"2021","journal-title":"Am J Public Health"},{"issue":"3","key":"zoi220609r10","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","article-title":"Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE demonstration study.","volume":"86","author":"Roth","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"zoi220609r11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/ciw701","article-title":"Uptake of HIV preexposure prophylaxis among commercially insured persons\u2014United States, 2010-2014.","volume":"64","author":"Wu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi220609r12","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/1475-6773.12293","article-title":"Using medical claims for policy effectiveness surveillance: reimbursement and utilization of abdomen\/pelvis computed tomography scans.","volume":"50","author":"Horn\u00fd","year":"2015","journal-title":"Health Serv Res"},{"issue":"2","key":"zoi220609r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi220609r14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.ajem.2018.11.015","article-title":"Do confidentiality concerns impact pre-exposure prophylaxis willingness in emergency department adolescents and young adults?","volume":"37","author":"Moore","year":"2019","journal-title":"Am J Emerg Med"},{"key":"zoi220609r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108764","article-title":"Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.","volume":"225","author":"Morgan","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi220609r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108280","article-title":"A collision of crises: addressing an HIV outbreak among people who inject drugs in the midst of COVID-19.","volume":"124","author":"Taylor","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"14","key":"zoi220609r17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMp1804306","article-title":"Being PrEPared\u2014 preexposure prophylaxis and HIV disparities.","volume":"379","author":"Goldstein","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi220609r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22692","article-title":"Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system.","volume":"4","author":"Hojilla","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zoi220609r19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsat.2019.08.015","article-title":"Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island.","volume":"106","author":"Peterson","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"zoi220609r20","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.2105\/AJPH.2018.304561","article-title":"HIV preexposure prophylaxis as a gateway to primary care.","volume":"108","author":"Marcus","year":"2018","journal-title":"Am J Public Health"},{"issue":"1","key":"zoi220609r21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11606-020-06201-6","article-title":"\u201cHealth is on the back burner:\u201d multilevel barriers and facilitators to primary care among people who inject drugs.","volume":"36","author":"Motavalli","year":"2021","journal-title":"J Gen Intern Med"},{"key":"zoi220609r22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.","volume":"85","author":"Morgan","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"zoi220609r23","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s10461-021-03220-0","article-title":"HIV pre-exposure prophylaxis and buprenorphine at a drug detoxification center during the opioid epidemic: opportunities and challenges.","volume":"25","author":"Assoumou","year":"2021","journal-title":"AIDS Behav"},{"issue":"5","key":"zoi220609r24","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review.","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"key":"zoi220609r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108540","article-title":"Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder.","volume":"133","author":"Morgan","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi220609r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.5042","article-title":"New USPSTF guidelines for HIV screening and preexposure prophylaxis (PrEP): straight A\u2019s.","volume":"2","author":"Walensky","year":"2019","journal-title":"JAMA Netw Open"},{"key":"zoi220609r26","first-page":"394","article-title":"HIV care providers emphasize the importance of the Ryan White program for access to and quality of care.","volume-title":"Health Aff","author":"Sood","year":"2014"},{"key":"zoi220609r3","unstructured":"US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 update: a clinical practice guideline. Accessed November 11, 2021. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"zoi220609r28","unstructured":"US Department of Health and Human Services. HIV National Strategic Plan for the United States: A Roadmap to End the Epidemic 2021\u20132025. 2021. Accessed November 11, 2021. https:\/\/hivgov-prod-v3.s3.amazonaws.com\/s3fs-public\/HIV-National-Strategic-Plan-2021-2025.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794155\/streed_2022_oi_220609_1657054232.54284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T15:31:49Z","timestamp":1657639909000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.21346","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}